FDA finds no heart attack risk with HIV drug
Key points
- An analysis of 26 clinical trials found no higher risk of heart attacks with AIDS drug abacavir compared with other HIV medicines, U.S. health officials said on Tuesday.
- The Food and Drug Administration reviewed data on abacavir after studies showed conflicting information about a possible link to heart attacks.
- Abacavir is an ingredient in HIV drugs Ziagen, Trizivir and Epzicom sold by ViiV Healthcare, a joint venture between GlaxoSmithKline Plc and Pfizer Inc.
- The FDA said doctors should continue to prescribe abacavir as directed.
An analysis of 26 clinical trials found no higher risk of heart attacks with AIDS drug abacavir compared with other HIV medicines, U.S. health officials said on Tuesday.
The Food and Drug Administration reviewed data on abacavir after studies showed conflicting information about a possible link to heart attacks.
Abacavir is an ingredient in HIV drugs Ziagen, Trizivir and Epzicom sold by ViiV Healthcare, a joint venture between GlaxoSmithKline Plc and Pfizer Inc. Glaxo is the majority partner.
The FDA said doctors should continue to prescribe abacavir as directed. The agency had disclosed it was reviewing the heart attack data in 2008.
###
WASHINGTON
(Reuters)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →NewsAnger linked to raised heart attack risk
Bottling up emotions is thought to harm both mind and body, but a new study suggests that the opposite extreme may be no better. In a study of thousands of heart attack patients, those who recalled having flown into a…
15 May 2013
NewsCommon Erectile Dysfunction Drug Not Helpful for Heart Failure Patients, Study Finds
A commonly used erectile dysfunction drug, sildenafil, doesn't help patients who have heart failure with preserved ejection fraction, a condition in which the heart's lower chambers are stiff and cannot relax and fill…
13 March 2013
NewsCT angiography helps predict heart attack risk
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk…
